Literature DB >> 26777278

Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration.

Marta Valenza1, Roberto Picetti2, Vadim Yuferov3, Eduardo R Butelman3, Mary Jeanne Kreek3.   

Abstract

The aim of the present study was to investigate alterations in gene expression of opioid system components induced by extended access (18 h) cocaine self-administration and to determine the impact of genetic background in the vulnerability to escalate cocaine intake. Comparing two inbred rat strains, we previously reported that Lewis rats progressively escalated cocaine consumption compared to Fischer rats, in a new translational model of intravenous cocaine self-administration, which included 14 sessions of 18-h operant sessions in which rats were allowed to select the cocaine unit dose to self-administer. We compare here Fischer and Lewis rats in the gene expression of endogenous opioid peptides (Pomc, Penk, Pdyn) and cognate receptors (Oprm, Oprk and Oprd) in reward-related brain regions, after exposure to either cocaine self-administration or yoked-saline, in the aforementioned translational paradigm. We performed a correlation analysis between the mRNA level, found in the Dorsal Striatum (DS), Nucleus accumbens (NAcc) shell and core respectively, and individual cocaine intake. Our findings show that the gene expression of all the aforementioned opioid genes exhibit strain-dependent differences in the DS, in absence of cocaine exposure. Also, different strain-specific cocaine-induced mRNA expression of Oprm and Oprk was found in DS. Only few differences were found in the ventral parts of the striatum. Moreover, gene expression level of Pdyn, Penk, Oprk, and Oprm in the DS was significantly correlated with cocaine intake only in Fischer rats. Overall, these data shed light on potential genetic differences which may predispose of subjects to initiate and escalate cocaine consumption.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cocaine addiction; Dorsal striatum; Dynorphin; Extended access self-administration; Kappa opioid receptor; Nucleus accumbens; Opioid peptides; Opioid receptors

Mesh:

Substances:

Year:  2016        PMID: 26777278      PMCID: PMC4894495          DOI: 10.1016/j.neuropharm.2016.01.004

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  96 in total

Review 1.  How fast and how often: The pharmacokinetics of drug use are decisive in addiction.

Authors:  Florence Allain; Ellie-Anna Minogianis; David C S Roberts; Anne-Noël Samaha
Journal:  Neurosci Biobehav Rev       Date:  2015-06-24       Impact factor: 8.989

2.  Profiles of substance use disorders in patients of therapeutic communities: link to social, medical and psychiatric characteristics.

Authors:  David Fernández-Calderón; Fermín Fernández; Sofía Ruiz-Curado; Antonio Verdejo-García; Óscar M Lozano
Journal:  Drug Alcohol Depend       Date:  2015-01-20       Impact factor: 4.492

3.  Behavior genetic investigation of the relationship between spontaneous locomotor activity and the acquisition of morphine self-administration behavior.

Authors:  E. Ambrosio; S.R. Goldberg; G.I. Elmer
Journal:  Behav Pharmacol       Date:  1995-04       Impact factor: 2.293

4.  Extinction of cocaine self-administration produces a differential time-related regulation of proenkephalin gene expression in rat brain.

Authors:  J A Crespo; J Manzanares; J M Oliva; J Corchero; T Palomo; E Ambrosio
Journal:  Neuropsychopharmacology       Date:  2001-08       Impact factor: 7.853

5.  Strain differences in patterns of drug-intake during prolonged access to cocaine self-administration.

Authors:  Kevin B Freeman; David N Kearns; Stephen J Kohut; Anthony L Riley
Journal:  Behav Neurosci       Date:  2009-02       Impact factor: 1.912

6.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  Strain differences between Lewis and Fischer 344 rats in the modulation of dopaminergic receptors after morphine self-administration and during extinction.

Authors:  Pilar Sánchez-Cardoso; Alejandro Higuera-Matas; Sonsoles Martín; Miguel Miguéns; Nuria Del Olmo; Carmen García-Lecumberri; Emilio Ambrosio
Journal:  Neuropharmacology       Date:  2009-04-17       Impact factor: 5.250

Review 8.  Epigenetic mechanisms of drug addiction.

Authors:  Eric J Nestler
Journal:  Neuropharmacology       Date:  2013-04-30       Impact factor: 5.250

9.  The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine.

Authors:  T S Shippenberg; C Heidbreder
Journal:  Eur J Pharmacol       Date:  1995-06-23       Impact factor: 4.432

10.  Morphine-induced mu opioid receptor trafficking enhances reward yet prevents compulsive drug use.

Authors:  Amy Chang Berger; Jennifer L Whistler
Journal:  EMBO Mol Med       Date:  2011-06-08       Impact factor: 12.137

View more
  14 in total

1.  Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats.

Authors:  Kathy Steece-Collier; Timothy J Collier; Jack W Lipton; Jennifer A Stancati; Mary E Winn; Allyson Cole-Strauss; Rhyomi Sellnow; Melissa M Conti; Natosha M Mercado; Eduardo A Nillni; Caryl E Sortwell; Fredric P Manfredsson; Christopher Bishop
Journal:  Exp Neurol       Date:  2020-05-05       Impact factor: 5.330

2.  Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity?

Authors:  Eduardo Roque Butelman; Silvia Bacciardi; Angelo Giovanni Icro Maremmani; Maya Darst-Campbell; Joel Correa da Rosa; Mary Jeanne Kreek
Journal:  Am J Addict       Date:  2017-06-27

3.  "Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats".

Authors:  Marta Valenza; Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2017-05-27       Impact factor: 4.530

4.  Bidirectional influence of heroin and cocaine escalation in persons with dual opioid and cocaine dependence diagnoses.

Authors:  Eduardo R Butelman; Carina Y Chen; Kimberly J Lake; Kate G Brown; Mary Jeanne Kreek
Journal:  Exp Clin Psychopharmacol       Date:  2020-10-29       Impact factor: 3.157

5.  Sex and heredity are determinants of drug intake in a novel model of rat oral oxycodone self-administration.

Authors:  Burt M Sharp; Xinyu Fan; Eva E Redei; Megan K Mulligan; Hao Chen
Journal:  Genes Brain Behav       Date:  2021-09-16       Impact factor: 3.449

6.  Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.

Authors:  Rhyomi C Sellnow; Kathy Steece-Collier; Feras Altwal; Ivette M Sandoval; Jeffrey H Kordower; Timothy J Collier; Caryl E Sortwell; Anthony R West; Fredric P Manfredsson
Journal:  J Neurosci       Date:  2020-04-01       Impact factor: 6.167

7.  Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat.

Authors:  Marta Valenza; Kyle A Windisch; Eduardo R Butelman; Brian Reed; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2020-01-08       Impact factor: 4.530

8.  Glucose Intake Alters Expression of Neuropeptides Derived from Proopiomelanocortin in the Lateral Hypothalamus and the Nucleus Accumbens in Fructose Preference Rats.

Authors:  Guangfa Jiao; Guozhong Zhang; Haiying Wang; Weilin Zhao; Yanwei Cui; Yongjing Liu; Feng Gao; Fang Yuan; Yi Zhang
Journal:  Neural Plast       Date:  2017-11-08       Impact factor: 3.599

9.  Looking for a Treatment for the Early Stage of Alzheimer's Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin.

Authors:  Roberta Facchinetti; Marta Valenza; Maria Rosanna Bronzuoli; Giorgia Menegoni; Patrizia Ratano; Luca Steardo; Patrizia Campolongo; Caterina Scuderi
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

Review 10.  The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data.

Authors:  José Manuel Lerma-Cabrera; Francisca Carvajal; James C Garbutt; Montserrat Navarro; Todd E Thiele
Journal:  Brain Res       Date:  2019-12-28       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.